2,2'-dipicolylamine has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, K; Lin, J; Liu, G; Lv, G; Qiu, L; Wang, S; Wang, W; Zhao, X | 1 |
Ayesa, U; Chong, PL; Gray, BD; Pak, KY | 1 |
Azeredo, NF; Borges, LJH; Bull, ÉS; Carvalho, ECQ; Fernandes, C; Freitas, WR; Horn, A; Jerdy, H; Kanashiro, MM; Lemos, LS; Resende, JALC | 1 |
3 other study(ies) available for 2,2'-dipicolylamine and Neoplasms
Article | Year |
---|---|
Synthesis and preliminary biological evaluation of a
Topics: Amines; Animals; Chlorambucil; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Picolinic Acids; Radiopharmaceuticals; Renal Elimination; Technetium | 2017 |
Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.
Topics: Amines; Anions; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Drug Carriers; Humans; Lipid Bilayers; Liposomes; MCF-7 Cells; Membrane Fusion; Nanoparticles; Neoplasms; Phosphatidylcholines; Phosphatidylserines; Picolinic Acids; Unilamellar Liposomes; Zinc | 2017 |
In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Coordination Complexes; Copper; Humans; Leukemia; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pyridines | 2016 |